Skip to main content

Figure 2.

Figure 2.

Perspectives in cancer immunotherapy. The conversion of “cold” tumor (low TIL population) to “hot” tumor (high TIL population) has the potential to improve the efficacy of current immune therapy. Various approaches to establish a TME that is friendly to T-cell immunity may be considered, such as by combining current ICB and ACT therapy.